Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr 22;22(4):672.
doi: 10.3390/molecules22040672.

Modified Nucleotides as Substrates of Terminal Deoxynucleotidyl Transferase

Affiliations

Modified Nucleotides as Substrates of Terminal Deoxynucleotidyl Transferase

Daiva Tauraitė et al. Molecules. .

Abstract

The synthesis of novel modified nucleotides and their incorporation into DNA sequences opens many possibilities to change the chemical properties of oligonucleotides (ONs), and, therefore, broaden the field of practical applications of modified DNA. The chemical synthesis of nucleotide derivatives, including ones bearing thio-, hydrazino-, cyano- and carboxy groups as well as 2-pyridone nucleobase-containing nucleotides was carried out. The prepared compounds were tested as substrates of terminal deoxynucleotidyl transferase (TdT). The nucleotides containing N⁴-aminocytosine, 4-thiouracil as well as 2-pyridone, 4-chloro- and 4-bromo-2-pyridone as a nucleobase were accepted by TdT, thus allowing enzymatic synthesis of 3'-terminally modified ONs. The successful UV-induced cross-linking of 4-thiouracil-containing ONs to TdT was carried out. Enzymatic post-synthetic 3'-modification of ONs with various photo- and chemically-reactive groups opens novel possibilities for future applications, especially in analysis of the mechanisms of polymerases and the development of photo-labels, sensors, and self-assembling structures.

Keywords: 4-bromo-2-pyridone; 4-chloro-2-pyridone; 4-thio-2’-deoxyuridine triphosphate; N4-amino-2’-deoxycytidine triphosphate; UV cross-linking; terminal deoxynucleotidyl transferase.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Scheme 1
Scheme 1
Synthesis of 4-thio-2’-deoxyuridine triphosphate (3) and N4-amino-2’-deoxycytidine triphosphate (4). Reagents and conditions: (i) Ac2O, NaOAc, 90 °C, 30 min; (ii) Lawesson’s reagent, toluene, 90 °C, 2 h; (iii) NaOCH3, CH3OH, rt, 30 min; (iv) POCl3, Bu3N, trimethyl phosphate, 0 °C, 90 min; then Bu3N, (NHBu3)2H2P2O7, CH3CN, 0 °C, 15 min; (v) NH2-NH2, H2O, rt, 18 h.
Scheme 2
Scheme 2
Synthesis of 5-cyano- and 5-carboxy-dUTP. Reagents and conditions: (i) 1,1,1,3,3,3-hexamethyldisilazane (HMDS), trimethylsilyl chloride (TMSCl), 80 °C, 4h; then 1,3,5-O-triacetyl-2-deoxyribose, SnCl4, rt, 5 h; (ii) NaOCH3, CH3OH, rt, 30 min; (iii) POCl3, Bu3N, trimethyl phosphate, 0–4 °C, 2–3 h; then Bu3N, (NHBu3)2H2P2O7, CH3CN, 0 °C, 10–15 min.
Figure 1
Figure 1
Polyacrylamide gel electrophoresis (PAGE) analysis of primer extension reactions (PEX) with terminal deoxynucleotidyl transferase (TdT) in glutamate/Mg2+ buffer. Lane 1, primer labelled at the 5'-end with a radioactive isotope of phosphorus (5’-33P-labelled primer); lanes 2–12, products of PEX using: lane 2, 2’-deoxythymidine triphosphate (dTTP); lane 3, 2’-deoxyuridine triphosphate (dUTP); lane 4, 2’-deoxycytidine triphosphate (dCTP); lane 5, 2-pyridone-2’-deoxyriboside triphosphate (dPyrTP); lane 6, dPyr4OHTP; lane 7, dPyr4ClTP; lane 8, dPyr4BrTP; lane 9, dPyr5COOHTP; lane 10, 4-thio-dUTP; lane 11, dU5CNTP; lane 12, dU5COOHTP; lane 13, N4-amino-dCTP.
Figure 2
Figure 2
PAGE analysis of PEX with TdT in cacodylate/Co2+ buffer. Lane 1, 5′-33P-labelled primer; lanes 2–12, products of PEX using: lane 2, dTTP; lane 3, dUTP; lane 4, dCTP; lane 5, dPyrTP; lane 6, dPyr4OHTP; lane 7, dPyr4ClTP; lane 8, dPyr4BrTP; lane 9, dPyr5COOHTP; lane 10, 4-thio-dUTP; lane 11, dU5CNTP; lane 12, dU5COOHTP; lane 13, N4-amino-dCTP.
Figure 3
Figure 3
PAGE analysis of cross-linked complexes of 4-thio-dU-ONs and TdT. Lane 1, recombinant TdT; lane 2, molecular mass marker (kDa); lane 3, 4-thio-dU-ON:TdT UV-free control; lane 4, cross-linked complexes of 4-thio-dU-ON:TdT, dose of UV irradiation ~17.2 J/cm2; lane 5, cross-linked complexes of 4-thio-dU-ON:TdT, dose of UV irradiation ~4.6 J/cm2; lane 6, cross-linked complexes of 4-thio-dU-ON:TdT (excess of TdT), dose of UV irradiation ~17.2 J/cm2; lane 7; dU-ON:TdT control, dose of UV irradiation ~17.2 J/cm2.

Similar articles

Cited by

References

    1. Meek K.N., Rangel A.E., Heemstra J.M. Enhancing aptamer function and stability via in vitro selection using modified nucleic acids. Methods. 2016;106:29–36. doi: 10.1016/j.ymeth.2016.03.008. - DOI - PubMed
    1. Lipi F., Chen S., Chakravarthy M., Rakesh S., Veedu R.N. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies. RNA Biol. 2016;13:1232–1245. doi: 10.1080/15476286.2016.1236173. - DOI - PMC - PubMed
    1. Kraemer S., Vaught J.D., Bock C., Gold L., Katilius E., Keeney T.R., Kim N., Saccomano N.A., Wilcox S.K., Zichi D., et al. From SOMAmer-based biomarker discovery to diagnostic and clinical applications: A SOMAmer-based, streamlined multiplex proteomic assay. PLoS ONE. 2011;6:e26332. doi: 10.1371/journal.pone.0026332. - DOI - PMC - PubMed
    1. Tjong V., Tang L., Zauscher S., Chilkoti A. ‘‘Smart’’ DNA interfaces. Chem. Soc. Rev. 2014;43:1612–1626. doi: 10.1039/C3CS60331H. - DOI - PubMed
    1. Xiang B., He K., Zhu R., Liu Z., Zeng S., Huang Y., Nie Z., Yao S. Self-assembled DNA hydrogel based on enzymatically polymerized DNA for protein encapsulation and enzyme/DNAzyme hybrid cascade reaction. Appl. Mater. Interfaces. 2016;8:22801–22807. doi: 10.1021/acsami.6b03572. - DOI - PubMed

MeSH terms